Recursion Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
RXRX Nasdaq 2834 www.recursion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Aug 5th, 2026 4:26 pm
Recursion Pharmaceuticals Q2 Earnings Call Highlights - Aug 5th, 2026 1:04 pm
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update - Aug 5th, 2026 9:13 am
Recursion Pharmaceuticals (RXRX) Stock Still Looks Expensive Following August 5 Results Update - Aug 5th, 2026 6:12 am
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Misses Revenue Estimates - Aug 5th, 2026 5:45 am
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program - Aug 5th, 2026 4:30 am
Recursion to Participate in Upcoming Investor Conferences - Aug 4th, 2026 6:00 am
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules - Jul 31st, 2026 2:30 pm
Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Jul 29th, 2026 3:45 pm
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th - Jul 29th, 2026 6:30 am
Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider - Jul 27th, 2026 3:50 pm
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed - Jul 24th, 2026 7:10 am
Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know - Jul 20th, 2026 3:50 pm
Why Recursion Pharmaceuticals (RXRX) Outpaced the Stock Market Today - Jul 14th, 2026 3:50 pm
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? - Jul 14th, 2026 3:17 am
2 Beaten-Down Stocks That Still Aren't Worth Buying - Jul 11th, 2026 2:50 pm
Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires? - Jul 9th, 2026 11:29 am
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market - Jul 8th, 2026 3:50 pm
Recursion Pharmaceuticals (RXRX) Is Up 8.0% After Russell Index Additions Expand Its Investor Base – Has The Bull Case Changed? - Jul 5th, 2026 7:09 pm
Recursion Pharmaceuticals (RXRX) Stock Looks Fully Valued Despite AI Drug Hopes - Jul 5th, 2026 5:10 pm